| CAS: | 138489-18-6 |
| 分子式: | C25H23N5O2S·CH4O3S |
| 分子量: | 553.65 |
| 用途: | Bisindolylmaleimide IX (Ro 31-8220 Mesylate)是一种pan-PKC抑制剂,作用于PKC-α, PKC-βI, PKC-βII, PKC-γ和PKC-ε,IC50分别为5 nM, 24 nM, 14 nM, 27 nM和24 nM,也有效抑制MAPKAP-K1b, MSK1, GSK3β和S6K1。RO31-8220抑制大鼠脑蛋白激酶C活性,IC 50为23 nM,在PKC-α,PKC-β,PKC-γ,PKC-ε之间没有选择性。[1] RO31-8220也抑制MSK1,MAPKAPK1,RSK,GSK3β和S6K1,具有对PKC相似的效力。此外,RO31-8220抑制电压依赖性钠离子通道。[2] RO31-8220改变细胞蛋白激酶C的定位并有效抑制A549细胞和MCF-7细胞的生长,IC 50分别为0.78 μM和0.897μM。[3] 在儿茶酚胺低反应血小板中,RO31-8220通过增强Akt的磷酸化增强了肾上腺素诱导的血小板聚集。[4] 通过抑制apoE基因的囊泡运输到质膜,RO31-8220显著降低载脂蛋白E从原代人巨噬细胞的分泌,没有显著影响ApoE的mRNA水平或蛋白水平。[5] |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||
| B793666 | MACKLIN | Bisindolylmaleimide IX (Ro 31-8220 Mesylate) | 10mM in DMSO | 1108元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||
| B872634 | MACKLIN | Bisindolylmaleimide IX (Ro 31-8220 Mesylate) | 99% | 255元/5mg; 457元/25mg; 1285元/100mg; 2625元/250mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
储存:-20℃ 状态:固体 | |||||||||||||||||||||||||||||||||||||||||||||||
| R136 | Sigma-Aldrich | Ro 31-8220 methanesulfonate salt | solid | 2410.17元/1 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Ro 31-8220是星形孢菌素的一种双吲哚基马来酰亚胺衍生物。Ro 31-8220可阻断MAP激酶磷酸酶-1(MKP-1)的表达、诱导c-Jun表达并刺激Jun N末端激酶(JNK1)。它具有免疫抑制特性。 包装 1, 5 mg in glass bottle 生化/生理作用 抑制GRK-5(G蛋白偶联受体激酶);PKC(蛋白激酶C);MAPKAP激酶1β及p70 S6激酶。 特点和优势 该化合物在受体分类和信号转导手册中GRK、GSK-3、 MAPKAP以及PKC页面中进行了详细介绍。如需浏览其他手册页,请点击此处。 注意 光敏性 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||
| 557520 | Sigma-Aldrich | Ro-31-8220-CAS 138489-18-6-Calbiochem | A cell-permeable, reversible, competitive, and selective inhibitor of protein kinase C (PKC; IC₅₀ = 10 nM) over CaM kinase II (IC₅₀ = 17 µM) and protein kinase A (IC₅ | 1954.93元/500 μG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 A cell-permeable, reversible, competitive, and selective inhibitor of protein kinase C (PKC; IC50 = 10 nM) over CaM kinase II (IC50 = 17 µM) and protein kinase A (IC50 = 900 nM). Potently inhibits GSK-3 in primary adipocytes (IC50 = 6.8 nM) and in GSK-3β immunoprecipitates (IC50 = 2.8 nM). An inhibitor of MAP kinase phosphatase-1 expression and an activator of JNK1. Inhibits the phosphorylation of Raf-1 and induces apoptosis, independent of its effects on PKC, in HL-60 cells. Also inhibits sirtuin in a NAD-competitive manner (IC50 = 3.5 µM and 0.8 µM for SIRT1 and SIRT2, respectively), and induces hyperacetylation of tubulin in A549 cells. A 5 mM (500 µg/181 µl) solution of Ro-31-8220 (Cat. No. 557521) in H2O is also available. 包装 500 μg in Plastic ampoule 生化/生理作用 Cell permeable: yes 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). DMSO stock solutions are stable for up to 4 months at -20°C. 其他说明 Trapp, J., et al. 2006. J. Med. Chem.In press. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||